Norwood Health Ctr-central | |
1600 N Chestnut Ave, Marshfield, Wisconsin 54449 | |
(715) 384-2188 | |
Name | Norwood Health Ctr-central |
---|---|
Location | 1600 N Chestnut Ave, Marshfield, Wisconsin |
Certified By | Medicaid |
No. of Certified Beds | 32 |
Occupancy Rate | 50.94% |
Medicare ID (CCN) | 52A251 |
Legal Business Name | Legal Business Name Not Available |
Ownership Type | Government - County |
NPI Number | 1457334922 |
Organization Name | COUNTY OF WOOD |
Doing Business As | NORWOOD HEALTH CENTER - LTC |
Address | 1600 N Chestnut Ave, Marshfield, WI 54449 |
Phone Number | 715-384-2188 |
News Archive
Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced that it has initiated a Phase 2 clinical trial of arhalofenate (MBX-102), its product candidate for the management of hyperuricemia in patients with gout.
Low-income people dealing with hearing loss just got a little hope. Doctors from Michigan Medicine's Department of Otolaryngology - Head and Neck Surgery partnered with the Hope Clinic to create Hope for Hearing, a program that provides free hearing aids to uninsured adults.
A plant which had previously been dismissed as not being medically useful, could prove to be a hero in disguise, after scientists discovered it not only stops the growth of breast cancer cells but does not affect normal cells - a potential first for future cancer chemotherapy treatment.
Vaccines are successful in preventing pandemic flu and reducing the number of patients hospitalised as a result of the illness, a study led by academics at The University of Nottingham has found.
› Verified 6 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced that it has initiated a Phase 2 clinical trial of arhalofenate (MBX-102), its product candidate for the management of hyperuricemia in patients with gout.
Low-income people dealing with hearing loss just got a little hope. Doctors from Michigan Medicine's Department of Otolaryngology - Head and Neck Surgery partnered with the Hope Clinic to create Hope for Hearing, a program that provides free hearing aids to uninsured adults.
A plant which had previously been dismissed as not being medically useful, could prove to be a hero in disguise, after scientists discovered it not only stops the growth of breast cancer cells but does not affect normal cells - a potential first for future cancer chemotherapy treatment.
Vaccines are successful in preventing pandemic flu and reducing the number of patients hospitalised as a result of the illness, a study led by academics at The University of Nottingham has found.
› Verified 6 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 10.39 | 14.46 |
Percentage of long-stay residents who lose too much weight | 1.35 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 11.11 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 1.2 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 0 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 58.33 | 14.2 |